Selected articles
Articles for label Důra Miroslav are displayed.. Show all articles
Skin toxicity of immunotherapy
02/2020 MUDr. Miroslav Důra
Cancer immunotherapy has become a therapeutic routine in increasing number of diagnoses. Beside the established antitumoral efficacy, a range of specific adverse events is now well-known including the immunological basis of the evolution. The article summarizes the most frequent types of skin toxicity in immunotherapy. Severity assessment is presented according to the new version of CTCAE (Common Terminology Criteria for Adverse Events). Current recommendations of ESMO (European Society for Medical Oncology) and NCCN (National Comprehensive Cancer Network) are taken into account in the treatment management.
ENTIRE ARTICLE
Cancer immunotherapy has become a therapeutic routine in increasing number of diagnoses. Beside the established antitumoral efficacy, a range of specific adverse events is now well-known including the immunological basis of the evolution. The article summarizes the most frequent types of skin toxicity in immunotherapy. Severity assessment is presented according to the new version of CTCAE (Common Terminology Criteria for Adverse Events). Current recommendations of ESMO (European Society for Medical Oncology) and NCCN (National Comprehensive Cancer Network) are taken into account in the treatment management.
A story of a football coach playing guitar
02/2019 MUDr. Miroslav Důra
This case report describes a treatment response in a patient with metastatic melanoma, who was treated with nivolumab. Objective response and also visible improvement of his quality of life were observed.
ENTIRE ARTICLE
This case report describes a treatment response in a patient with metastatic melanoma, who was treated with nivolumab. Objective response and also visible improvement of his quality of life were observed.